Document Detail


What is high risk? Redefining elevated pulmonary vascular resistance index in pediatric heart transplantation.
MedLine Citation:
PMID:  22019236     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Currently, pulmonary vascular resistance index (PVRI) >6 WU × m(2) (indexed units) is generally considered a contraindication to isolated orthotopic heart transplantation (OHT). However, this has been questioned in the literature. METHODS: A retrospective review was performed on all patients <18 years old who underwent primary OHT for cardiomyopathy. Data were collected with regard to demographics, pre-operative hemodynamics, need for pre-operative mechanical circulatory support, vasodilator reactivity and 30-day mortality (30dM). A receiver operating characteristic (ROC) curve was used to establish an optimal threshold. Uni- and multivariate logistic regressions were performed to assess the influence of PVRI on 30dM. RESULTS: Complete data were available for 158 cardiomyopathy patients <18 years of age, who underwent primary OHT between June 1984 and November 2010. The ROC curve yielded a threshold of 9.290 indexed units. Four of 19 patients (21.1%) with PVRI >9 died in the first 30 days. In patients with PVRI <9, there was only 1 death among 139 patients (0.7%). Odds of mortality increased incrementally with PVRI as a continuous variable, with an odds ratio (OR) of 1.35 per indexed unit (95% confidence interval 1.12 to 1.63). PVRI was dichomotomized (PVRId) using the previously established threshold and revealed an increasing risk of mortality, OR 36.80 (95% confidence interval 3.86 to 350.90), with a PVRI of >9 indexed units. CONCLUSIONS: Using a PVRI >6 as a contraindication to isolated OHT may be too restrictive. Patients with PVRI ≤9 do not appear to be at increased risk of early mortality. In patients with PVRI >9, 30-day survival was 78.9% in this study. This represents a viable alternative to heart-lung transplantation.
Authors:
Peter Chiu; Mark J Russo; Ryan R Davies; Linda J Addonizio; Marc E Richmond; Jonathan M Chen
Related Documents :
21968026 - A prospective study of percutaneous vertebroplasty in patients with myeloma and spinal ...
21609796 - Reinterventions during midterm follow-up after endovascular treatment of thoracic aorti...
21715446 - Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in ...
8583066 - Matched hemiresection interposition arthroplasty of the distal radioulnar joint.
11641586 - Long-term follow-up of patients after intraarterial thrombolytic therapy of acute verte...
9102436 - The endoscopic treatment of cerebrospinal fluid rhinorrhoea: the nottingham experience.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-21
Journal Detail:
Title:  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation     Volume:  -     ISSN:  1557-3117     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9102703     Medline TA:  J Heart Lung Transplant     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Affiliation:
Department of Surgery, Columbia University, College of Physicians & Surgeons, New York, New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inter-Rater Agreement of the Goutallier, Patte, and Warner Classification Scores Using Preoperative ...
Next Document:  Permanent Breast Seed Implant Dosimetry Quality Assurance.